TAMPA, Fla., March 6, 2018 /PRNewswire/ — Excite Medical, headquartered in Tampa, Florida, recently finalized the acquisition of all intellectual property associated with the popular DRX9000™ True Non-Surgical Spinal Decompression® System previously owned by Axiom Worldwide®, announced Excite Medical founder and president Saleem Musallam.
Included in the purchase are all applications, programs, designs, drawings, source codes, schematics, and U.S. FDA 510(k) certificates for all DRX9000™ spinal decompression devices along with four trademarks, including the “DRX®” mark.
“This intellectual property perfectly positions Excite Medical to develop, sell, service, and market the DRX9000™,” said Musallam, adding, “It’s central to our growth strategy.”
“DRX® treatment has proved to be a leading technology for the non-surgical and drug-free treatment of chronic lower back pain, like that due to herniated disc, bulging disc, and degenerative disc disease. Clinics and Hospitals in some 45 countries are now effectively using the DRX9000™ and there are more than 2,400 systems in use worldwide,” he added.
Research conducted by physicians from leading medical schools and research institutions, including the Mayo Clinic, Johns Hopkins University, Stanford, and University of California, San Francisco, demonstrated that DRX® treatment is more than 88 percent effective treating patients with chronic lower back pain. Their results were published in the peer-reviewed Journal of Medicine.
Musallam founded Excite Medical in 2007 and since that time has been growing its customer base and support services around its flagship product, the DRX9000™ non-surgical spinal decompression system. The company has the largest inventory of both DRX9000™ and DRX9000C True Non-Surgical Spinal Decompression® equipment and a distribution network that spans the Americas, Europe, and Asia.
Musallam has more than 20 years of experience in customer service, sales, management, and distribution. His career has taken him to more than 40 countries and he credits his knowledge of foreign markets for the success Excite Medical has enjoyed in furthering the adoption of DRX® technology around the world.